Yanhong Shi, Ph.D., Beckman Research Institute of City of Hope. Progress is being made to treat cancer patients suffering from degenerative brain diseases. Scientists at City of Hope, one of the largest cancer research and treatment organizations in the United States, have developed universal donor stem cells that could one day provide lifesaving therapy to … Continue reading Universal donor stem cells could one day provide lifesaving therapy for lethal brain conditions
Finding solutions for affordable and accessible cell and gene therapies
The California Institute for Regenerative Medicine (CIRM) is not alone in seeking a way to make cell and gene therapies more affordable and accessible. The Innovative Genomics Institute (IGI) just completed a year-long effort to consider how treatments could be made more accessible. This effort involved creating a task force comprised of 30 participants to … Continue reading Finding solutions for affordable and accessible cell and gene therapies
CIRM invests $50 million in clinical research, including trial for vision loss
The California Institute for Regenerative Medicine (CIRM), the world’s largest institution dedicated to regenerative medicine, today awarded $50.1 million to fund clinical-stage research projects aimed at advancing stem cell and gene therapy treatments for a variety conditions ranging from neurodegenerative diseases and blood cancers to HIV/AIDS. The awards will support six projects in the Agency’s … Continue reading CIRM invests $50 million in clinical research, including trial for vision loss
Kevin Xu joins governing board of California’s Stem Cell & Gene Therapy Agency
The California Institute for Regenerative Medicine (CIRM), the world’s largest institution dedicated to regenerative medicine, is pleased to announce the appointment of Kevin Xu to its Independent Citizens’ Oversight Committee (ICOC), the official governing Board of the agency. Xu is CEO of MEBO International, an intellectual property management company responsible for managing “Human Body Regenerative … Continue reading Kevin Xu joins governing board of California’s Stem Cell & Gene Therapy Agency
Novartis acquisition validates CIRM’s impact on cystinosis treatment
Dr. Stephanie Cherqui The future looks brighter for cystinosis patients and their families. As one of 7,000 rare diseases, cystinosis causes an abnormal build-up of the amino acid cystine that can lead to organ failure and premature death. With little to no treatment options, children and young adults primarily affected by the condition often have … Continue reading Novartis acquisition validates CIRM’s impact on cystinosis treatment
CIRM invests $10 million to build California Cell and Gene Therapy Manufacturing Network
A laboratory at UCLA's current good manufacturing practices facility | Photo credit: Elena Zhukova The California Institute for Regenerative Medicine (CIRM), the world’s largest institution dedicated to regenerative medicine, awarded $10 million to five facilities as part of the first phase to build a California Cell and Gene Therapy Manufacturing Network. The awards include: Application … Continue reading CIRM invests $10 million to build California Cell and Gene Therapy Manufacturing Network
CIRM team shines at ASGCT annual meeting in sunny Los Angeles
The California Institute for Regenerative Medicine (CIRM) team spent a week in sunny Los Angeles spreading awareness of its mission at the American Society of Gene & Cell Therapy (ASGCT) annual meeting. The goal of the meeting is to provide a place for people in the cell and gene therapy field to learn from the … Continue reading CIRM team shines at ASGCT annual meeting in sunny Los Angeles
Apply now! Translational research funding, applications due June 13th
The California Institute for Regenerative Medicine (CIRM) is pleased to announce the next round of funding opportunities for Translational (TRAN) research projects. Click here to access the Program Announcement. The objective of this program is to fund promising stem cell-based and gene therapy projects that accelerate completion of translational stage activities necessary for advancement to clinical study or broad … Continue reading Apply now! Translational research funding, applications due June 13th
How CIRM-funded research is bringing a lifesaving gene therapy to a 5-year-old
For her first year of life, Seersha Sulack stayed mostly in her bedroom because something as simple as a common cold could have killed her. The five-year-old was born with ADA-SCID, a condition so rare that only eight babies a year are born with it in the United States. Now, thanks to the work of … Continue reading How CIRM-funded research is bringing a lifesaving gene therapy to a 5-year-old
#Take6ForPD: CIRM Board member David Higgins shares why Parkinson’s awareness matters
April is Parkinson’s Awareness Month and the California Institute for Regenerative Medicine (CIRM) is joining the campaign to #Take6ForPD—take 6 minutes to raise Parkinson’s awareness and highlight our commitment to funding research for the disease. In addition to highlighting our commitment to funding research for Parkinson's Disease, we're also giving patients and patient advocates the opportunity to … Continue reading #Take6ForPD: CIRM Board member David Higgins shares why Parkinson’s awareness matters
The Stem Cellar 